Retatrutide

Retatrutide (LY3437943): a triple-receptor research peptide stocked in Australia and New Zealand

Retatrutide is a laboratory-made research peptide, coded LY3437943 and often shortened to “Reta.” It is a triple agonist, or tri-agonist (a single molecule that switches on three receptors at once), and its three targets are the GLP-1, GIP and glucagon receptors. Neurogen Research holds Retatrutide in Australia and New Zealand as a lyophilised (freeze-dried) powder, supplied only for in-vitro (test-tube and cell) laboratory study.

Key highlights

• Compound: Retatrutide (LY3437943), a triple GLP-1/GIP/glucagon agonist research peptide.
• Purity & testing: latest COA 99.706% by HPLC (lot DRX122), third-party tested by Janoshik.
• Form: white lyophilised (freeze-dried) powder in a sealed vial.
• Sizes: 10mg, 20mg, 30mg and 50mg vials (single or with a starter kit).
• Dispatch: same-day from Sydney on orders before 12pm AEST, free express over $200 ($14.95 under).
• Use: in-vitro laboratory research only (not for human or animal use).

Is Retatrutide a peptide? A plain explanation

Retatrutide is a peptide, a short chain of amino acids (the small building blocks that also make up proteins). It is built in a lab to one exact sequence, so it is synthetic rather than drawn from a plant or animal, and it is not a steroid. An agonist is any molecule that turns a receptor on; most peptides in this area reach one receptor, or two, while Retatrutide was engineered to reach three together, which is why the three pathways are studied as a set.

How researchers study Retatrutide

Because one molecule of Retatrutide engages three receptors, laboratories use it to observe how those signals behave together rather than in isolation. A standard in-vitro test measures how much peptide is needed to switch each receptor on. Published work reports it is most potent at the GIP receptor, then GLP-1, and least at glucagon, with EC50 values of roughly 0.06, 0.8 and 5.8 nM (EC50 is the concentration that produces half the maximum response, so a smaller number means more potent). Carrying all three actions in one compound makes it a useful comparison point for peptides that reach only one or two receptors, such as the dual GIP/GLP-1 agonist Tirzepatide.

Where Retatrutide fits in metabolic research

In the lab, Retatrutide is a steady reference compound across metabolic and receptor studies, and it sits within our Metabolic Research range. Typical experiments track how it activates the GLP-1, GIP and glucagon receptors in cell models. It is also set against peptides that work through other pathways, such as Cagrilintide, an amylin analogue (a lab-made copy of a different metabolic hormone), to separate out what the added glucagon action contributes. Every use here stays on the bench, never in people or animals.

Retatrutide’s status: research use only

Retatrutide is an investigational compound, still under study and not cleared for use. It holds no approval from the Therapeutic Goods Administration (the TGA, which regulates medicines in Australia), the FDA, or any comparable body for medical, veterinary or personal use. Neurogen Research supplies it purely as a laboratory reference material: not a medicine, supplement, cosmetic or consumer product, and nothing here is medical advice. Supply is limited to qualified researchers who can store and handle it correctly.

Quality checks: purity and Certificate of Analysis (CoA)

Every batch of Retatrutide is tested by Janoshik, an independent third-party laboratory, before listing. Purity is read by HPLC (high-performance liquid chromatography, which separates a sample so its purity can be measured) and the latest COA reads 99.706% (lot DRX122), and a blind identity test against other GLP-1 peptides confirms the sample is Retatrutide. A Certificate of Analysis (CoA) travels with every order, and the batch reports are posted on our certificates page, so the figures can be matched against the exact vial you receive.

Where to buy Retatrutide in Australia and New Zealand: sizes and delivery

• Neurogen Research is Australian-based and keeps its stock here, so your Retatrutide order never crosses a border or waits in customs.
• Buy Retatrutide online in 10mg, 20mg, 30mg and 50mg vials, as a single vial or with a starter kit.
• Orders leave our Sydney facility by tracked Australia Post Express, dispatched the same day when placed before 12pm AEST.
• Metro (city) areas usually get delivery in 2 to 4 business days, regional (country) areas in 3 to 5, and New Zealand in 4 to 6; express is free on orders over $200 ($14.95 flat below that).

Handling, storage, and reconstitution

• Store the sealed freeze-dried vial below 25°C and out of direct light for short periods, or near -20°C for longer storage.
• To reconstitute the powder (turn it into a solution), labs use sterile or bacteriostatic water under clean conditions.
• Keep the mixed solution refrigerated and use it within a few weeks; because repeated freezing and thawing breaks peptides down, many labs divide it into single-use portions before freezing.

Retatrutide at a glance: technical data

Retatrutide: common questions

What is Retatrutide (LY3437943)?

Retatrutide is a synthetic research peptide classed as a triple agonist, since it switches on the GLP-1, GIP and glucagon receptors at once. It was developed under the code LY3437943 and appears in in-vitro (test-tube and cell) studies of metabolic pathways.

Is Retatrutide a peptide or a steroid?

It is a peptide, not a steroid. Retatrutide is a synthetic chain of amino acids with a molecular weight of about 4731 g/mol, which places it clearly in the peptide group.

How pure is Neurogen Research Retatrutide?

The latest COA shows 99.706% purity by HPLC (lot DRX122). It is tested by Janoshik, and a blind identity test confirms the sample is Retatrutide. A Certificate of Analysis ships with every order, so you can check the result against your own vial.

Is Retatrutide tested by an outside lab?

Yes. Each batch is assessed by Janoshik, an independent third-party laboratory, not in-house, for purity and identity, and the certificate can be viewed before or after ordering.

How should Retatrutide be stored?

Keep the sealed powder cool (below 25°C) and out of light for the short term, and near -20°C for longer holds. Once it is mixed with sterile or bacteriostatic water, store it in the fridge and avoid repeated freeze-thaw cycles.

Can I buy Retatrutide in Australia and New Zealand?

Yes. Neurogen Research holds Retatrutide in Australia and ships it across Australia and New Zealand from Sydney by tracked Australia Post Express, with same-day dispatch on orders placed before 12pm AEST. Supply is for laboratory research use only.

What vial sizes does Retatrutide come in?

Retatrutide is offered in 10mg, 20mg, 30mg and 50mg vials, alone or in a starter-kit bundle. The milligram figure is how much powder the vial holds, not a dose.

Is Retatrutide approved for human or medical use?

No. It is strictly an investigational research chemical, with no clearance from the TGA or any other regulator for treating people or for veterinary use.

Disclaimer: Retatrutide is provided only for in-vitro laboratory research. It is not a medicine, supplement, or cosmetic, and must not be used in humans or animals. By placing an order, you confirm that you are a qualified researcher and will store, handle, and use it in keeping with all relevant Australian and New Zealand laws and safety standards.